251 related articles for article (PubMed ID: 17517063)
61. Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus.
Gondar V; Molina-Jiménez F; Hishiki T; García-Buey L; Koutsoudakis G; Shimotohno K; Benedicto I; Majano PL
J Virol; 2015 Oct; 89(19):9962-73. PubMed ID: 26202245
[TBL] [Abstract][Full Text] [Related]
62. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
Gottwein JM; Bukh J
Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
[TBL] [Abstract][Full Text] [Related]
63. Cellular receptors and HCV entry.
Flint M; Tscherne DM
Methods Mol Biol; 2009; 510():265-77. PubMed ID: 19009268
[TBL] [Abstract][Full Text] [Related]
64. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
65. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
Leistner CM; Gruen-Bernhard S; Glebe D
Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
[TBL] [Abstract][Full Text] [Related]
66. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
67. Effect of lipoprotein lipase on binding of chylomicrons to LDL receptor-deficient Chinese hamster ovary cells.
Kobayashi J; Tashiro J; Bujo H; Morisaki N; Saito Y
Ann Clin Biochem; 2001 Mar; 38(Pt 2):124-8. PubMed ID: 11269752
[TBL] [Abstract][Full Text] [Related]
68. Claudin-1 and its potential role in HCV entry: another piece of the puzzle.
Hamilton JP; Thuluvath PJ
J Clin Gastroenterol; 2008 Jan; 42(1):3-4. PubMed ID: 18097281
[No Abstract] [Full Text] [Related]
69. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.
Schaefer EA; Meixiong J; Mark C; Deik A; Motola DL; Fusco D; Yang A; Brisac C; Salloum S; Lin W; Clish CB; Peng LF; Chung RT
World J Gastroenterol; 2016 Dec; 22(45):9954-9965. PubMed ID: 28018102
[TBL] [Abstract][Full Text] [Related]
70. Screening of small-molecule compounds as inhibitors of HCV entry.
Yang JP; Zhou D; Wong-Staal F
Methods Mol Biol; 2009; 510():295-304. PubMed ID: 19009270
[TBL] [Abstract][Full Text] [Related]
71. [Research on hepatitis C virus entry inhibitor].
Zeng Wenting ; Lu X; Wang J; Jin X; Zhu J
Bing Du Xue Bao; 2015 Jan; 31(1):97-105. PubMed ID: 25997338
[TBL] [Abstract][Full Text] [Related]
72. The mechanism of HCV entry into host cells.
Douam F; Lavillette D; Cosset FL
Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801
[TBL] [Abstract][Full Text] [Related]
73. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
74. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.
Dao Thi VL; Granier C; Zeisel MB; Guérin M; Mancip J; Granio O; Penin F; Lavillette D; Bartenschlager R; Baumert TF; Cosset FL; Dreux M
J Biol Chem; 2012 Sep; 287(37):31242-57. PubMed ID: 22767607
[TBL] [Abstract][Full Text] [Related]
75. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
76. Very low density lipoprotein and low density lipoprotein isolated from patients with hepatitis C infection induce altered cellular lipid metabolism.
Napolitano M; Giuliani A; Alonzi T; Mancone C; D'Offizi G; Tripodi M; Bravo E
J Med Virol; 2007 Mar; 79(3):254-8. PubMed ID: 17245726
[TBL] [Abstract][Full Text] [Related]
77. Role of lipid metabolism in hepatitis C virus assembly and entry.
Popescu CI; Dubuisson J
Biol Cell; 2009 Oct; 102(1):63-74. PubMed ID: 19857204
[TBL] [Abstract][Full Text] [Related]
78. Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins.
Mancone C; Steindler C; Santangelo L; Simonte G; Vlassi C; Longo MA; D'Offizi G; Di Giacomo C; Pucillo LP; Amicone L; Tripodi M; Alonzi T
Gut; 2011 Mar; 60(3):378-86. PubMed ID: 20940285
[TBL] [Abstract][Full Text] [Related]
79. Binding of low density lipoproteins to lipoprotein lipase is dependent on lipids but not on apolipoprotein B.
Boren J; Lookene A; Makoveichuk E; Xiang S; Gustafsson M; Liu H; Talmud P; Olivecrona G
J Biol Chem; 2001 Jul; 276(29):26916-22. PubMed ID: 11331277
[TBL] [Abstract][Full Text] [Related]
80. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
Syder AJ; Lee H; Zeisel MB; Grove J; Soulier E; Macdonald J; Chow S; Chang J; Baumert TF; McKeating JA; McKelvy J; Wong-Staal F
J Hepatol; 2011 Jan; 54(1):48-55. PubMed ID: 20932595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
